Description

Pyridazine, 1,4,5,6-Tetrahydro-1,3,6-Trimethyl-4-Phenyl-, trans- (8Ci) is a specialized heterocyclic organic compound belonging to the pyridazine class, characterized by its unique trans-configuration and phenyl substitution. This compound serves as a valuable advanced pharmaceutical intermediate and a versatile building block in organic synthesis, enabling the construction of complex molecular architectures. It is primarily sought by research and development teams in the pharmaceutical, agrochemical, and fine chemical industries for the development of new active ingredients and functional materials.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and development of novel drug candidates, particularly in central nervous system (CNS) and cardiovascular therapeutic areas.
• Agrochemical Synthesis: Used in the creation of advanced herbicides, fungicides, and insecticides, leveraging its heterocyclic core for biological activity.
• Ligand and Catalyst Development: Serves as a scaffold for designing novel ligands in coordination chemistry and catalysis for asymmetric synthesis.
• Material Science Research: Investigated as a monomer or additive for creating specialized polymers and organic electronic materials.
• Academic & Industrial R&D: Employed in methodological studies and as a building block for constructing complex heterocyclic libraries in combinatorial chemistry.

Basic Information

Item	Details
Product Name	Pyridazine, 1,4,5,6-Tetrahydro-1,3,6-Trimethyl-4-Phenyl-, trans- (8Ci)
CAS No.	802291-77-6
Molecular Formula	C14H20N2
Molecular Weight	216.33 g/mol
Synonyms	trans-1,3,6-Trimethyl-4-phenyl-1,4,5,6-tetrahydropyridazine; 4-Phenyl-1,4,5,6-tetrahydropyridazine, 1,3,6-trimethyl-, trans-; 1,4,5,6-Tetrahydro-1,3,6-trimethyl-4-phenylpyridazine; (4R)-1,3,6-Trimethyl-4-phenyl-4,5-dihydro-1H-pyridazine; (4S)-1,3,6-Trimethyl-4-phenyl-4,5-dihydro-1H-pyridazine (enantiomer); trans-Trimethylphenyltetrahydropyridazine
EINECS	Contact for details

Quality Control

Our production of Pyridazine, 1,4,5,6-Tetrahydro-1,3,6-Trimethyl-4-Phenyl-, trans- (8Ci) adheres to stringent quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC, GC, NMR, and chiral purity analysis, to ensure identity, potency, and purity meet exacting standards. A Certificate of Analysis (COA) detailing all specifications is provided with each shipment to guarantee traceability and compliance for your R&D and scale-up processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from strong oxidizing agents. For long-term storage, consider an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee (or as specified)
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.